Lv31
340 积分 2023-09-05 加入
A New Scale for Evaluating Disability in Multiple Sclerosis
2小时前
待确认
On the evaluation of disability in multiple sclerosis
2小时前
待确认
Emerging drugs for the acute treatment of relapses in adult neuromyelitis optica spectrum disorder patients
28天前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
30天前
已完结
Tafolecimab: First Approval
1个月前
已完结
Evolocumab: First Global Approval
1个月前
已完结
Alirocumab: First Global Approval
1个月前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
3个月前
已完结
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies
3个月前
已完结
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
3个月前
已完结
皖公网安备34019202002308
